Trial Outcomes & Findings for Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer (NCT NCT03375489)
NCT ID: NCT03375489
Last Updated: 2025-05-16
Results Overview
Compare the difference between study groups in patient-reported quality of life as measured by the Functional Assessment of Cancer Therapy - Lung Questionnaire, which has a total scale score range from 0-136 with higher scores indicating better overall quality of life.
COMPLETED
NA
1798 participants
24 Weeks
2025-05-16
Participant Flow
Note: Caregiver enrollment in the study and attendance at palliative care visits were voluntary, and patients could participate without an enrolled caregiver. Only one caregiver per patient participant was invited to enroll in the study.
Participant milestones
| Measure |
Telehealth Palliative Care: Patient
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Patient
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* Palliative care visits will be scheduled on the same day as an oncology visit if possible.
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
Telehealth Palliative Care: Caregiver
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
|
In-person Palliative Care: Caregiver
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* Palliative care visits will be scheduled on the same day as an oncology visit if possible.
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
633
|
617
|
272
|
276
|
|
Overall Study
COMPLETED
|
633
|
617
|
272
|
276
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Four caregiver participants in the Telehealth Palliative Care Group and two caregiver participants in the In-person Palliative Care group did not complete the age question on the socio-demographic questionnaire, and therefore their baseline age data are missing.
Baseline characteristics by cohort
| Measure |
Telehealth Palliative Care: Patient
n=633 Participants
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Patient
n=617 Participants
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* In-person palliative care visits will be scheduled on the same day as an oncology visit if possible.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
Telehealth Palliative Care: Caregiver
n=272 Participants
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Caregiver
n=276 Participants
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* In-person palliative care visits will be scheduled on the same day as an oncology visit if possible.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
Total
n=1798 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
|
65.5 years
STANDARD_DEVIATION 10.9 • n=633 Participants • Four caregiver participants in the Telehealth Palliative Care Group and two caregiver participants in the In-person Palliative Care group did not complete the age question on the socio-demographic questionnaire, and therefore their baseline age data are missing.
|
65.5 years
STANDARD_DEVIATION 10.6 • n=617 Participants • Four caregiver participants in the Telehealth Palliative Care Group and two caregiver participants in the In-person Palliative Care group did not complete the age question on the socio-demographic questionnaire, and therefore their baseline age data are missing.
|
56.8 years
STANDARD_DEVIATION 14.8 • n=268 Participants • Four caregiver participants in the Telehealth Palliative Care Group and two caregiver participants in the In-person Palliative Care group did not complete the age question on the socio-demographic questionnaire, and therefore their baseline age data are missing.
|
58.0 years
STANDARD_DEVIATION 13.2 • n=274 Participants • Four caregiver participants in the Telehealth Palliative Care Group and two caregiver participants in the In-person Palliative Care group did not complete the age question on the socio-demographic questionnaire, and therefore their baseline age data are missing.
|
63.0 years
STANDARD_DEVIATION 12.4 • n=1792 Participants • Four caregiver participants in the Telehealth Palliative Care Group and two caregiver participants in the In-person Palliative Care group did not complete the age question on the socio-demographic questionnaire, and therefore their baseline age data are missing.
|
|
Sex/Gender, Customized
Woman
|
356 Participants
n=633 Participants
|
318 Participants
n=617 Participants
|
182 Participants
n=272 Participants
|
194 Participants
n=276 Participants
|
1050 Participants
n=1798 Participants
|
|
Sex/Gender, Customized
Man
|
277 Participants
n=633 Participants
|
297 Participants
n=617 Participants
|
90 Participants
n=272 Participants
|
82 Participants
n=276 Participants
|
746 Participants
n=1798 Participants
|
|
Sex/Gender, Customized
Unknown or Not Reported
|
0 Participants
n=633 Participants
|
2 Participants
n=617 Participants
|
0 Participants
n=272 Participants
|
0 Participants
n=276 Participants
|
2 Participants
n=1798 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
29 Participants
n=633 Participants
|
30 Participants
n=617 Participants
|
10 Participants
n=272 Participants
|
14 Participants
n=276 Participants
|
83 Participants
n=1798 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
596 Participants
n=633 Participants
|
575 Participants
n=617 Participants
|
255 Participants
n=272 Participants
|
255 Participants
n=276 Participants
|
1681 Participants
n=1798 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
8 Participants
n=633 Participants
|
12 Participants
n=617 Participants
|
7 Participants
n=272 Participants
|
7 Participants
n=276 Participants
|
34 Participants
n=1798 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
4 Participants
n=633 Participants
|
4 Participants
n=617 Participants
|
2 Participants
n=272 Participants
|
1 Participants
n=276 Participants
|
11 Participants
n=1798 Participants
|
|
Race/Ethnicity, Customized
Asian
|
32 Participants
n=633 Participants
|
32 Participants
n=617 Participants
|
9 Participants
n=272 Participants
|
12 Participants
n=276 Participants
|
85 Participants
n=1798 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
57 Participants
n=633 Participants
|
72 Participants
n=617 Participants
|
17 Participants
n=272 Participants
|
22 Participants
n=276 Participants
|
168 Participants
n=1798 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
|
2 Participants
n=633 Participants
|
4 Participants
n=617 Participants
|
0 Participants
n=272 Participants
|
2 Participants
n=276 Participants
|
8 Participants
n=1798 Participants
|
|
Race/Ethnicity, Customized
White
|
524 Participants
n=633 Participants
|
502 Participants
n=617 Participants
|
238 Participants
n=272 Participants
|
235 Participants
n=276 Participants
|
1499 Participants
n=1798 Participants
|
|
Race/Ethnicity, Customized
Other
|
21 Participants
n=633 Participants
|
10 Participants
n=617 Participants
|
7 Participants
n=272 Participants
|
2 Participants
n=276 Participants
|
40 Participants
n=1798 Participants
|
|
Race/Ethnicity, Customized
Unknown or Not Reported
|
3 Participants
n=633 Participants
|
6 Participants
n=617 Participants
|
1 Participants
n=272 Participants
|
4 Participants
n=276 Participants
|
14 Participants
n=1798 Participants
|
|
Region of Enrollment
United States
|
633 participants
n=633 Participants
|
617 participants
n=617 Participants
|
272 participants
n=272 Participants
|
276 participants
n=276 Participants
|
1798 participants
n=1798 Participants
|
PRIMARY outcome
Timeframe: 24 WeeksPopulation: The analysis population represents the numbers of patients in each study group who completed the baseline and 24-week Functional Assessment of Cancer Therapy - Lung Questionnaire.
Compare the difference between study groups in patient-reported quality of life as measured by the Functional Assessment of Cancer Therapy - Lung Questionnaire, which has a total scale score range from 0-136 with higher scores indicating better overall quality of life.
Outcome measures
| Measure |
Telehealth Palliative Care: Patients
n=305 Participants
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Patients
n=315 Participants
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* In-person palliative care visits will be scheduled on the same day as an oncology visit if possible.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
|---|---|---|
|
Patient-reported Quality of Life
|
99.7 units on a scale
Interval 98.0 to 101.3
|
97.7 units on a scale
Interval 96.1 to 99.3
|
SECONDARY outcome
Timeframe: 48 weeks (or last assessment prior to death if before 48 weeks)Population: The analysis population represents the numbers of patients in each study group who completed the Prognosis and Treatment Perceptions Questionnaire at least once post baseline up to 48 weeks.
Compare the difference between study groups in the proportion of patients who reported that they discussed their end-of-life care preferences with their clinicians based on a single item from the Prognosis and Treatment Perceptions Questionnaire (PTPQ). The PTPQ includes a self-report item that assesses whether the patient communicated with their clinicians about their wishes for care if they were dying (i.e., scored dichotomously as "yes vs. no").
Outcome measures
| Measure |
Telehealth Palliative Care: Patients
n=446 Participants
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Patients
n=442 Participants
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* In-person palliative care visits will be scheduled on the same day as an oncology visit if possible.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
|---|---|---|
|
Patient-reported Communication About Their End-of-Life Care Preferences With Their Clinicians
|
130 Participants
|
115 Participants
|
SECONDARY outcome
Timeframe: From hospice enrollment until patient death during study periodPopulation: The analysis population represents the numbers of patients in each study group who who died during the study period.
Compare the difference between study groups in the length of stay in hospice (as measured in days) among patients who died during study period per medical record review.
Outcome measures
| Measure |
Telehealth Palliative Care: Patients
n=360 Participants
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Patients
n=363 Participants
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* In-person palliative care visits will be scheduled on the same day as an oncology visit if possible.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
|---|---|---|
|
Length of Stay in Hospice
|
25.3 days
Interval 19.2 to 31.3
|
25.1 days
Interval 19.0 to 31.1
|
SECONDARY outcome
Timeframe: 24 weeksPopulation: The analysis population represents the numbers of patients in each study group who had any palliative care visits, and the overall number of units analyzed represents the numbers of palliative care visits in each study group through week 24.
Compare the difference between study groups in the proportion of palliative care visits that had a caregiver present as documented by the palliative care clinician using a study visit summary form.
Outcome measures
| Measure |
Telehealth Palliative Care: Patients
n=2618 Number of Palliative Care Visits
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Patients
n=2588 Number of Palliative Care Visits
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* In-person palliative care visits will be scheduled on the same day as an oncology visit if possible.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
|---|---|---|
|
Proportion of Patient's Palliative Care Visits With a Caregiver Present
|
36.6 proportion of visits with a caregiver
Interval 33.6 to 39.7
|
49.7 proportion of visits with a caregiver
Interval 46.4 to 53.1
|
SECONDARY outcome
Timeframe: 24 weeksPopulation: The analysis population represents the numbers of patients in each study group who completed the 24-week Satisfaction and Care Delivery Questionnaire.
Compare the difference between study groups in patient-reported satisfaction with care as measured by the Satisfaction and Care Delivery Questionnaire, which has a total scale score range from 0-52 with higher scores indicating greater satisfaction.
Outcome measures
| Measure |
Telehealth Palliative Care: Patients
n=422 Participants
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Patients
n=422 Participants
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* In-person palliative care visits will be scheduled on the same day as an oncology visit if possible.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
|---|---|---|
|
Patient-reported Satisfaction With Care
|
41.3 units on a scale
Interval 40.4 to 42.3
|
41.0 units on a scale
Interval 40.1 to 41.9
|
SECONDARY outcome
Timeframe: 24 weeksPopulation: The analysis population represents the numbers of caregivers in each study group who completed the 24-week Satisfaction and Care Delivery Questionnaire.
Compare the difference between study groups in caregiver-reported satisfaction with care as measured by the Satisfaction and Care Delivery Questionnaire (caregiver version), which has a total scale score range from 0-48 with higher scores indicating greater satisfaction.
Outcome measures
| Measure |
Telehealth Palliative Care: Patients
n=176 Participants
* Patient and caregiver will meet with the palliative care clinician in person within four weeks of enrollment.
* Subsequent visits with the palliative care clinician will be conducted with the patient and caregiver in their home or other location using video at least every four weeks.
* Patient and caregiver may be scheduled to meet with the palliative care clinician in the clinic if requested by the patient or a clinician.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
Telehealth Palliative Care: Teleconference meeting via video with the palliative care team. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
In-person Palliative Care: Patients
n=177 Participants
* Patient and caregiver will be scheduled for their first in-person palliative care visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic.
* In-person palliative care visits will be scheduled on the same day as an oncology visit if possible.
(Note: Caregiver enrollment in the study and attendance at palliative care visits are voluntary, and the patient can participate without an enrolled caregiver.)
In-person Palliative Care: In-person meeting with the palliative care team in clinic. Palliative care is a medical specialty focused on lessening (or "palliating") patients' symptoms and helping patients and their families cope with a serious illness.
|
|---|---|---|
|
Caregiver-reported Satisfaction With Care
|
37.2 units on a scale
Interval 35.8 to 38.5
|
36.8 units on a scale
Interval 35.4 to 38.2
|
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 48 weeksCompare the difference between study groups in patient-reported coping strategies as measured by the Brief Cope (approach-oriented coping score range: 6-24, with higher scores indicating greater use of approach-oriented coping strategies; avoidant coping score range: 4-16, with higher scores indicating greater use of avoidant coping strategies).
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 48 weeksCompare the difference between study groups in patient-reported prognostic understanding as measured by the Prognosis and Treatment Perceptions Questionnaire, in which patients rate two items about the goal of their cancer care (i.e., scored dichotomously as either "to cure my cancer" vs any other option) and whether their cancer is curable (i.e., scored dichotomously as "yes or no").
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 48 weeksCompare the difference between study groups in caregiver-reported prognostic understanding as measured by the Prognosis and Treatment Perceptions Questionnaire, in which caregivers rate two items about the goal of their loved one's cancer care (i.e., scored dichotomously as either "to cure his/her cancer" vs any other option) and whether their loved one's cancer is curable (i.e., scored dichotomously as "yes or no").
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 48 weeksCompare the difference between study groups in caregiver-reported quality of life as measured by the Caregiver Oncology Quality of Life Questionnaire, which has a total scale score range of 0-100 with higher scores indicating better quality of life.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 48 weeksCompare the difference between study groups in caregiver-reported mood symptoms as measured by the Hospital Anxiety and Depression Scale (anxiety subscale score range, 0-21, with higher scores indicating greater anxiety symptoms; depression subscale score range, 0-21, with higher scores indicating greater depression symptoms).
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 48 weeksCompare the difference between study groups in patient-reported mood symptoms as measured by the Hospital Anxiety and Depression Scale (anxiety subscale score range, 0-21, with higher scores indicating greater anxiety symptoms; depression subscale score range, 0-21, with higher scores indicating greater depression symptoms).
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 48 weeksCompare the difference between study groups in patient-reported depression as measured by the Patient Health Questionnaire-9, which has a total scale score range from 0-27 with higher scores indicating more significant depression symptoms.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Through study completion, average of 18 month follow upCompare the difference between study groups in health care utilization as per medical record review of emergency department visits, hospital admissions, chemotherapy administration at the end of life, and hospice service use.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Up to 6 months after patient death during study periodCompare the difference between study groups in caregiver-reported quality of patient death as measured by the After Death Assessment, which includes three items that ask the caregiver to rate the quality of the patient's death (from 1 "worst possible" to 10 "best possible"), the degree of physical distress the patient experienced in their last week of life (from 1 "none" to 10 "extremely distressed"), and the degree of psychological distress the patient experienced in their last week of life (from 1 "none" to 10 "extremely upset").
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: up to 48 weeksCompare the difference between study groups in patient-reported quality of life across all study assessment time points as measured by the Functional Assessment of Cancer Therapy - Lung Questionnaire, which has a total scale score range from 0-136 with higher scores indicating better quality of life.
Outcome measures
Outcome data not reported
Adverse Events
Telehealth Palliative Care: Patients
In-person Palliative Care: Patients
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place